Hi everyone,

The Australian Stem Cell Centre's latest newsletter is now available. A lot has been going on, especially in the regulatory world. Here is a roundup of what has been happening:

You can read it online here, older newsletters are also available through our website.

Contents of this Month?s newsletter:

Stem Cell Research News
Skin Cells Converted into Heart Cells
iPS Cells Remember Their Past
Transplant Surgery Using Stem Cell Derived Trachea Successful
Bone Marrow Stem Cells Successfully Treat Lethal Skin Disorder
Bioscaffolds Promote Growth of Joints in Rabbits

Industry News
Geron?s Trial on Spinal Cord Injury Allowed to Continue
TCA Cellular Therapy Recruiting for Phase I Spinal Cord Injury Trial
Mesoblast Receives Regulatory Approval for Commercial Manufacture of Stem Cell Products
Athersys Reports Positive Results for Heart Attack Treatment
Axiogenesis In-Licenses Yamanaka Patent Portfolio from iPS Academia Japan Covering Induced Pluripotent Stem Cell Technology
Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair

Policy, Regulation, Ethics & Events News
IN FOCUS: National Science Week
US Food and Drug Administration (FDA) vs Regenerative Sciences of Colorado
Stem Cell Research Funding In Australia

Best wishes,

Australian Stem Cell Centre
View our patient handbook online